High-Dose Statins Increase Adverse Events and Do Not Improve Survival
J Am Coll Cardiol
.
2022 Oct 18;80(16):e125.
doi: 10.1016/j.jacc.2022.06.045.
Authors
Simon B Dimmitt
,
Hans G Stampfer
,
John B Warren
,
Jennifer H Martin
PMID:
36229095
DOI:
10.1016/j.jacc.2022.06.045
No abstract available
Publication types
Letter
Comment
MeSH terms
Cardiovascular Diseases*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors